GO:0106235 ceramide-1-phosphate phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106235 describes the enzymatic activity that removes phosphate from ceramide-1-phosphate (C1P) to produce ceramide and inorganic phosphate.
• This phosphatase activity was first biochemically characterized in brain and liver plasma membranes, where it regulates the balance between pro-apoptotic ceramide and pro-survival C1P.
• The reaction is distinct from sphingosine-1-phosphate phosphatase and is often assayed using radiolabeled or fluorescent substrates.
• C1P phosphatase activity influences sphingolipid signaling, membrane trafficking, and cell survival, with implications for neurodegeneration and cancer.
• Key proteins implicated in related pathways include ceramide kinase (CERK), neutral sphingomyelinase 2 (nSMase2), and sphingosine kinases, though the exact C1P phosphatase enzyme(s) remain under investigation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of candidate genes regulating C1P levels and phosphatase activity.
Description
Ceramide-1-phosphate phosphatase activity (GO:0106235) is a molecular function that catalyzes the hydrolysis of ceramide-1-phosphate (C1P) to ceramide and inorganic phosphate. This activity sits at a critical node in sphingolipid metabolism, opposing the action of ceramide kinase, which generates C1P from ceramide. By converting C1P back to ceramide, the phosphatase regulates the relative abundance of two lipid messengers with opposing roles: C1P promotes cell survival, proliferation, and inflammatory signaling, whereas ceramide is associated with growth arrest and apoptosis. The first biochemical evidence for this activity came from studies in rat brain and liver plasma membranes, where the enzyme was detected and partially characterized. Subsequent methodological advances allowed its measurement in various tissues and cell types. Despite its importance, the specific gene(s) encoding ceramide-1-phosphate phosphatase activity have not been definitively identified, making it a compelling target for functional genomics and CRISPR screening. Researchers study this activity to understand how cells maintain sphingolipid homeostasis, how dysregulation contributes to diseases such as cancer and neurodegeneration, and how it can be modulated therapeutically.
ceramide-1-phosphate phosphatase activity At A Glance
| GO ID | GO:0106235 |
|---|---|
| GO term | ceramide-1-phosphate phosphatase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of the hydrolysis of ceramide-1-phosphate to ceramide and phosphate |
| Reaction | ceramide-1-phosphate + H2O = ceramide + phosphate |
| Substrate | Ceramide-1-phosphate (C1P) |
| Products | Ceramide and inorganic phosphate |
| Cellular location | Plasma membrane, brain and liver tissues (as characterized) |
| Related activity | Sphingosine-1-phosphate phosphatase (distinct) |
| First characterized | Rat brain and liver plasma membranes (1993) |
What Is GO:0106235?
According to the Gene Ontology, GO:0106235 ceramide-1-phosphate phosphatase activity is defined as the catalysis of the reaction: ceramide-1-phosphate + H2O = ceramide + phosphate. In other words, it is the enzymatic removal of a phosphate group from ceramide-1-phosphate, yielding ceramide and free phosphate. This activity belongs to the molecular_function ontology aspect and is distinct from other lipid phosphatases such as sphingosine-1-phosphate phosphatase.
Why Is ceramide-1-phosphate phosphatase activity Important in Cell Biology?
Ceramide-1-phosphate phosphatase activity is crucial because it directly controls the cellular balance between ceramide and C1P, two sphingolipids with opposing biological functions. Ceramide is a well-known tumor suppressor lipid that promotes apoptosis and growth inhibition, while C1P is a pro-survival and pro-inflammatory mediator. By converting C1P to ceramide, this phosphatase acts as a molecular switch that can influence cell fate decisions, inflammatory responses, and membrane dynamics. Dysregulation of this activity has been linked to pathological conditions including neurodegeneration and cancer, making it a potential therapeutic target. Understanding its regulation and identifying the responsible enzymes are therefore high priorities in sphingolipid research.
• Regulates the ceramide/C1P rheostat, influencing cell survival versus apoptosis.
• Modulates inflammatory signaling pathways through C1P levels.
• Impacts membrane trafficking and lipid raft dynamics.
• Implicated in brain function and neurodegeneration, as shown in Huntington's disease models.
• Potential role in cancer biology via control of pro-survival C1P.
• Provides a target for pharmacological modulation of sphingolipid metabolism.
• Helps explain resistance to therapies that target ceramide kinase or sphingosine kinase.
• Essential for understanding lipidomic changes in neurological disorders.
• Enables development of assays for drug discovery targeting lipid phosphatases.
• Offers a paradigm for studying enzyme redundancy in lipid phosphate phosphatase families.
Molecular Mechanism of ceramide-1-phosphate phosphatase activity
Substrate recognition and binding
In simple terms: The enzyme grabs ceramide-1-phosphate and positions it for chemical reaction.
Ceramide-1-phosphate phosphatase specifically binds its substrate, ceramide-1-phosphate (C1P), within its active site. The enzyme likely recognizes the ceramide backbone and the phosphate group, distinguishing C1P from other lipid phosphates such as sphingosine-1-phosphate. This specificity ensures that the phosphatase does not indiscriminately dephosphorylate other sphingolipids, maintaining metabolic fidelity.
Catalytic hydrolysis
In simple terms: Water is used to split off the phosphate group from C1P, leaving ceramide.
The catalytic mechanism involves nucleophilic attack by a water molecule on the phosphate ester bond of C1P, resulting in the release of inorganic phosphate and ceramide. This hydrolysis reaction is typical of lipid phosphate phosphatases and may require divalent cations such as Mg2+ or Ca2+ for optimal activity, although the exact cofactor requirements for C1P phosphatase have not been fully defined.
Product release and membrane dynamics
In simple terms: After the reaction, ceramide and phosphate are released, and ceramide can alter membrane properties.
Following catalysis, the products ceramide and phosphate are released. Ceramide, being highly hydrophobic, remains in the membrane and can influence membrane curvature, raft formation, and signaling platforms. The release of phosphate into the cytosol contributes to cellular phosphate homeostasis. The enzyme itself may undergo conformational changes to reset for another catalytic cycle.
Regulation by cellular context
In simple terms: The activity of the phosphatase can change depending on cell type, signaling, and disease state.
Ceramide-1-phosphate phosphatase activity is not constant; it varies across tissues and can be modulated by cellular signals. For example, in brain and liver, the activity was found to be associated with plasma membranes and could be influenced by lipid environment. In disease contexts such as Huntington's disease, lipidomic remodeling suggests that C1P phosphatase activity may be altered, contributing to pathology. Additionally, cross-talk with ceramide kinase and sphingomyelinases can indirectly affect substrate availability.
Key Genes Involved in GO:0106235 ceramide-1-phosphate phosphatase activity
The following genes and proteins are implicated in ceramide-1-phosphate metabolism and related signaling pathways, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CERK | Ceramide kinase; produces C1P from ceramide | Opposing enzyme to C1P phosphatase; target for modulating C1P levels |
| SMPD2 | Neutral sphingomyelinase 2; generates ceramide from sphingomyelin | Regulates substrate availability for CERK and C1P production |
| SMPD3 | Neutral sphingomyelinase 3 | Involved in ceramide generation in brain; potential link to C1P phosphatase |
| SPHK1 | Sphingosine kinase 1; produces S1P | Related sphingolipid kinase; cross-talk with C1P pathways |
| SPHK2 | Sphingosine kinase 2; produces S1P | May influence sphingolipid rheostat and C1P phosphatase activity |
| SGPP1 | Sphingosine-1-phosphate phosphatase 1 | Distinct phosphatase; useful for comparative studies |
| SGPP2 | Sphingosine-1-phosphate phosphatase 2 | Distinct phosphatase; potential functional overlap |
| PLPP1 | Lipid phosphate phosphatase 1 | May exhibit broad specificity including C1P; candidate for C1P phosphatase activity |
| PLPP2 | Lipid phosphate phosphatase 2 | Another lipid phosphatase with potential C1P activity |
| PLPP3 | Lipid phosphate phosphatase 3 | Candidate C1P phosphatase; expressed in various tissues |
| DEGS1 | Dihydroceramide desaturase | Affects ceramide species available for C1P synthesis |
| ASAH1 | Acid ceramidase | Degrades ceramide; indirect effect on C1P levels |
| UGCG | Glucosylceramide synthase | Competes for ceramide; influences C1P production |
| CERS2 | Ceramide synthase 2 | Generates very long-chain ceramides; substrate for CERK |
| CERS4 | Ceramide synthase 4 | Generates ceramides; may impact C1P pools |
| CERS5 | Ceramide synthase 5 | Generates ceramides; potential link to C1P metabolism |
| CERS6 | Ceramide synthase 6 | Generates ceramides; may affect C1P phosphatase substrate availability |
| ACER1 | Alkaline ceramidase 1 | Hydrolyzes ceramide; cross-talk with C1P pathway |
How Is ceramide-1-phosphate phosphatase activity Regulated?
Ceramide-1-phosphate phosphatase activity is regulated at multiple levels. Substrate availability is controlled by ceramide kinase (CERK), which produces C1P, and by sphingomyelinases that generate ceramide. The activity can be influenced by membrane lipid composition, as the enzyme is membrane-associated. In disease states such as Huntington's disease, lipidomic changes suggest altered regulation of C1P metabolizing enzymes. Additionally, post-translational modifications and interacting proteins may modulate phosphatase activity, though specific mechanisms remain to be elucidated. Cross-talk with sphingosine-1-phosphate phosphatases indicates potential redundancy and coordinated regulation within the lipid phosphate phosphatase family.
ceramide-1-phosphate phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CERK | Cancer, inflammation | Knockout or overexpression in cancer cell lines; xenograft models |
| SMPD2 | Neurodegeneration, inflammation | Neuronal cell lines with KO; primary neurons |
| SMPD3 | Huntington's disease, brain development | Huntington's disease iPSC-derived neurons; KO mice |
| SPHK1 | Cancer, immune disorders | Knockout mice; tumor models |
| PLPP3 | Cardiovascular disease, cancer | Endothelial cell KO; zebrafish models |
Neurodegeneration and Huntington's disease
Lipidomic analysis of the subventricular zone in Huntington's disease models revealed significant alterations in sphingolipid metabolism, including changes in ceramide and C1P levels. These changes suggest that ceramide-1-phosphate phosphatase activity may be dysregulated in neurodegenerative conditions, contributing to disease pathology. The balance between ceramide and C1P is critical for neuronal survival, and shifts toward ceramide accumulation can promote neurodegeneration.
Cancer and cell survival
C1P is a pro-survival lipid that promotes cancer cell proliferation and resistance to apoptosis. Ceramide-1-phosphate phosphatase, by converting C1P to ceramide, acts as a tumor suppressor-like activity. Loss of this activity could lead to C1P accumulation and enhanced survival signaling, contributing to oncogenesis. Therefore, modulating this phosphatase is a potential therapeutic strategy in cancers with dysregulated sphingolipid metabolism.
Inflammation and immune signaling
C1P is a potent inflammatory mediator that stimulates eicosanoid synthesis and chemotaxis. The phosphatase that degrades C1P thus plays an anti-inflammatory role by reducing C1P levels. Dysregulation of this activity could contribute to chronic inflammatory diseases. Understanding the enzyme's regulation may offer targets for anti-inflammatory therapies.
From ceramide-1-phosphate phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of candidate phosphatase gene alter C1P levels? | CRISPR knockout in HEK293 or HeLa cells; lipidomics |
| Does a point mutation in the catalytic domain abolish activity? | CRISPR point mutation (e.g., H→A) in candidate gene; phosphatase assay |
| Can we tag the endogenous enzyme to study localization? | Knock-in of FLAG or GFP tag using CRISPR; imaging |
| Does overexpression of candidate gene reduce C1P and induce apoptosis? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression; flow cytometry |
| Which genes regulate C1P phosphatase activity? | Genome-wide CRISPR library screening with C1P fluorescent reporter |
| Does the enzyme interact with CERK or other lipid enzymes? | Knock-in of proximity labeling tags (BioID) followed by proteomics |
How to Study the ceramide-1-phosphate phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled C1P assay | Phosphatase activity | Enzyme kinetics in tissue lysates |
| Fluorescent C1P assay | Phosphatase activity | High-throughput screening |
| LC-MS lipidomics | C1P and ceramide levels | Disease model profiling |
| CRISPR knockout screen | Genes regulating C1P levels | Novel regulator discovery |
| CRISPR activation screen | Genes whose overexpression alters C1P | Pathway activation studies |
| Proximity labeling (BioID) | Protein-protein interactions | Identifying enzyme complexes |
| Live-cell imaging | Subcellular localization | Organelle dynamics |
| Phos-tag gel | Phosphatase activity in gel | Direct detection of activity |
Biochemical phosphatase assays
Ceramide-1-phosphate phosphatase activity is typically measured using radiolabeled [32P]C1P or fluorescent C1P analogs, followed by separation of products by thin-layer chromatography or high-performance liquid chromatography. These assays allow quantification of enzyme activity in cell lysates or membrane fractions. They are essential for validating candidate genes identified through genetic screens.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics enables comprehensive profiling of sphingolipids, including C1P and ceramide, in cells and tissues. This approach can reveal changes in C1P levels upon genetic manipulation of candidate phosphatases. It is particularly useful for studying disease models where lipid metabolism is perturbed, such as Huntington's disease.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can be designed to identify genes that regulate C1P levels or phosphatase activity. For example, a fluorescent C1P reporter can be used to sort cells with altered C1P content, followed by next-generation sequencing to identify enriched sgRNAs. This unbiased approach can uncover novel regulators of ceramide-1-phosphate phosphatase activity.
Imaging and subcellular localization
Fluorescence microscopy using tagged C1P-binding proteins or fluorescent C1P analogs can visualize C1P distribution in live cells. Knock-in of tagged candidate phosphatases allows tracking of their subcellular localization and dynamics. Co-localization with organelle markers can reveal where C1P hydrolysis occurs, such as plasma membrane or Golgi.
How CRISPR Can Be Used to Study GO:0106235 ceramide-1-phosphate phosphatase activity
Knockout
CRISPR knockout of candidate genes (e.g., PLPP1, PLPP2, PLPP3, SGPP1, SGPP2) can be used to test whether loss of function alters cellular C1P levels and phosphatase activity. Knockout cell lines are generated by introducing frameshift mutations in early exons, followed by validation of protein loss and lipidomic analysis. This approach helps identify the gene(s) responsible for ceramide-1-phosphate phosphatase activity.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in the catalytic domain of candidate phosphatases to abolish enzymatic activity without affecting protein expression or localization. For example, mutating a conserved histidine or aspartate residue in the lipid phosphatase motif can serve as a catalytically dead control. This is valuable for distinguishing enzymatic activity from scaffolding functions.
Knock-in
CRISPR knock-in can be used to tag endogenous candidate phosphatases with fluorescent proteins (e.g., GFP) or epitope tags (e.g., FLAG) to study their localization, dynamics, and interactions. Knock-in of a reporter for C1P (e.g., a C1P-binding domain fused to GFP) can also be achieved to monitor C1P levels in real time. These models provide physiological expression levels and avoid artifacts of overexpression.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase expression of candidate phosphatases to assess their impact on C1P levels, cell survival, and signaling. Overexpression of a bona fide C1P phosphatase should reduce C1P and increase ceramide, potentially inducing apoptosis or altering inflammatory responses. This approach complements loss-of-function studies.
How EDITGENE Supports ceramide-1-phosphate phosphatase activity Research
Researchers studying ceramide-1-phosphate phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in the regulation of C1P levels and downstream cellular phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies, from gene knockout to precise point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for ceramide-1-phosphate phosphatase activity research.
Frequently Asked Questions About ceramide-1-phosphate phosphatase activity
What is ceramide-1-phosphate phosphatase activity?
It is the enzymatic activity that removes phosphate from ceramide-1-phosphate to produce ceramide and phosphate, as defined by GO:0106235.
What genes are involved in ceramide-1-phosphate phosphatase activity?
The exact gene(s) remain unidentified, but candidate lipid phosphatases include PLPP1, PLPP2, PLPP3, SGPP1, and SGPP2.
How is ceramide-1-phosphate phosphatase activity measured?
It is typically measured using radiolabeled or fluorescent C1P substrates followed by chromatographic separation of products.
What is the difference between ceramide-1-phosphate phosphatase and sphingosine-1-phosphate phosphatase?
They are distinct activities with different substrates: C1P phosphatase acts on ceramide-1-phosphate, while S1P phosphatase acts on sphingosine-1-phosphate.
Why is ceramide-1-phosphate phosphatase important in cancer?
It converts pro-survival C1P to pro-apoptotic ceramide, so loss of activity may promote cancer cell survival.
Is ceramide-1-phosphate phosphatase involved in brain function?
Yes, activity was first characterized in brain, and lipidomic changes in Huntington's disease suggest a role in neurodegeneration.
What diseases are associated with ceramide-1-phosphate phosphatase dysfunction?
Neurodegeneration, cancer, and inflammatory conditions have been linked to altered C1P metabolism.
Can CRISPR be used to study ceramide-1-phosphate phosphatase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can help identify the responsible genes and dissect their functions.
What are the products of the ceramide-1-phosphate phosphatase reaction?
The products are ceramide and inorganic phosphate.
Where is ceramide-1-phosphate phosphatase located in the cell?
It has been detected in plasma membrane fractions of brain and liver, but may also localize to other membranes.
Conclusion
Ceramide-1-phosphate phosphatase activity (GO:0106235) is a key enzymatic function that regulates the balance between ceramide and C1P, two sphingolipids with opposing roles in cell survival and inflammation. Despite being biochemically characterized decades ago, the specific gene(s) responsible remain elusive, offering a rich area for functional genomics. CRISPR-based approaches are poised to identify these enzymes and elucidate their roles in health and disease. Understanding this activity could lead to new therapeutic strategies for cancer, neurodegeneration, and inflammatory disorders.
References
- 1. Shinghal R et al.. 1993. Ceramide 1-phosphate phosphatase activity in brain.. J Neurochem 61(6):2279-85 PMID: 8245978
- 2. Boudker O et al.. 1993. Detection and characterization of ceramide-1-phosphate phosphatase activity in rat liver plasma membrane.. J Biol Chem 268(29):22150-5 PMID: 8408075
- 3. Brindley DN et al.. 2000. Analysis of ceramide 1-phosphate and sphingosine-1-phosphate phosphatase activities.. Methods Enzymol 311:233-44 PMID: 10563330
- 4. Won JH et al.. 2018. Dopamine transporter trafficking is regulated by neutral sphingomyelinase 2/ceramide kinase.. Cell Signal 44:171-187 PMID: 29329781
- 5. Hunter M et al.. 2018. Subventricular zone lipidomic architecture loss in Huntington's disease.. J Neurochem 146(5):613-630 PMID: 29804301
